Skip to content

Author

Hakar Abdulkareem Saeed

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Dapagliflozin for attenuating early anthracycline-associated cardiac changes (DAPA-AIC): a randomized, double-blind, placebo-controlled trial.

AIMS To evaluate whether dapagliflozin attenuates early cardiac functional and biomarker changes during anthracycline-based chemotherapy. MATERIALS & METHODS In this randomized, double-blind, placebo-controlled phase II trial, 94 adults were assigned 1:1 to dapagliflozin 10 mg once daily or placebo for 4 months; 90 c...

Hakar Abdulkareem Saeed, N. M. Mohammed Ali, R. Othman · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.